Argus Research has upgraded Zimmer Biomet Holdings Inc. (NYSE:ZBH) on launching new products and tuck-in M&A to build future growth drivers.  One such driver is the ROSA system, which assists in robotic surgeries to implant replacement knee, hip, and shoulder joints. ROSA is also used in neurosurgery.  Another recent product launch is the cementless knee implant, which allows for shorter procedure times and helps to improve hospital staffing efficiency.  Related: What’s Going On With Zimmer Biomet Shares After Q1 Earnings? The analyst notes that Zimmer plans to introduce more than 40 new products over the next 24 ...